Departmental Highlights

Drs. Norman Shumway, left, and Donald C. Harrison meet the press after they perform the first adult human transplant in the United States in January 1968.

Stanford is able to leverage a series of "firsts," including the first heart transplant in the US, the first heart-lung transplant in the world, and one of the first left ventricular assist device (LVAD) procedures in the world. Stanford dominates the market in programs involving a high percentage of complex procedures. Several of Stanford's most successful cardiac programs have a broad geographical base, with over 20% of the volume for heart transplants, aorta and valve procedures coming from outside the Bay Area. Stanford also has a strong international cardiac market with cardiac patients representing more than 50% of overall international business. 

Dr. Bruce Reitz and his surgical team perform the world’s first successful combined adult human heart-lung transplant in 1981

Dameron Hospital Partners with Stanford Health Care

Dameron Hospital has partnered with Stanford Health Care to bring its world-class cardiothoracic surgery program to Stockton, extending Stanford’s reach in Northern California while eliminating the inconvenience of travel to the Bay Area for residents of the region.

Former Lung Transplant Patient of Dr. Jack Boyd Competes in World Transplant Games

"It has been an honor to participate in Erinn’s care," said Jack Boyd, M.D., clinical assistant professor at the Stanford University School of Medicine and cardiothoracic surgeon at Stanford Health Care, who performed Hoyt’s transplant surgery. "Her strength and determination to do amazing things both before and after her lung transplant are an inspiration to others with cystic fibrosis and to the physicians and health care providers who work with patients with this condition."

Department research, faculty prominently featured at the American Heart Association's Scientific Sessions 2017

Attracting nearly 20,000 attendees annually from around the world, the American Heart Association's Scientific Sessions is one of the most prominent forums for disseminating the latest breakthroughs in cardiovascular surgery and medicine. The Stanford Department of Cardiothoracic Surgery was well-represented at this year’s conference. The event began with an early career session, which focused on providing guidance and mentorship to trainees and young surgeons.

Dr. Mark Berry receives the 2017 Denise O’ Leary Award for Clinical Excellence

Dr. Mark Berry, Associate Professor of Cardiothoracic Surgery, received the 2017 Denise O’ Leary Award for Clinical Excellence on September 19, 2017. This award was started eight years ago as a lasting tribute to Denise’s commitment to excellence at Stanford Hospital. This award is considered the highest honor for physicians conducting patient care at Stanford Hospital.

Andrew Goldstone and Peter Chiu published in The New England Journal of Medicine

Article Title: "Prostheses for Aortic­ and Mitral ­Valve Replacement"

Valve ­replacement outcomes were examined with statewide data in California. Bioprostheses were associated with higher long­-term mortality than mechanical valves among patients up to 55 years of age for aortic ­valve replacement and up to 70 years of age for mitral­valve replacement. 

Ioannis Karakikes paper on genome editing of iPSCs featured on the cover of Circulation Research

Article Title: "Cardiomyopathy TALEN Knockout Library"

Karakikes and colleagues have now created a panel of gene editing constructs designed to target and disrupt 88 different genes associated with cardiovascular diseases. Introducing these individual constructs into human iPSCs and then differentiating the cells into cardiomyocytes should enable researchers to observe how a given mutation affects myocardial development.

Drs. Richard Ha and Joseph Woo use innovative method to keep teen alive for heart transplant

Abraham Maga's heart and lungs had failed and he would have died very quickly without an intervention. The traditional method of keeping Maga alive using a device called an ECMO (for extracorporeal membrane oxygenation) would have required he stay in bed until a heart was available for transplantation. Instead Dr. Richard Ha figured out a way to connect the device directly to Maga's heart rather than through an artery, allowing the boy to leave his bed and even leave the hospital.